Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells

Mol Cell Neurosci. 2003 Nov;24(3):632-45. doi: 10.1016/s1044-7431(03)00220-3.

Abstract

Ephrin-As are repulsive axonal guidance cues that regulate retinotectal projection. EphA tyrosine kinases, which are the receptors of ephrin-As, activate signaling cascades leading to cytosckeleton reorganization. Here, we address the role of cyclin-dependent kinase (Cdk) 5 in Eph receptor signaling induced by ephrin-A5. Ephrin-A5 induced a cell morphological response in PC-3M cells that endogenously express Cdk5 and EphA2, a receptor for ephrin-A5. This response was augmented by the transfection of p35, which is a neuronal regulator of Cdk5. While the morphological response of native PC-3M cells was not affected by olomoucine, an inhibitor of Cdk, the response was inhibited in the p35-transfected cells. In retinal ganglion cells, either olomoucine at 20 microM or Y-27632 at 10 microM, an inhibitor of Rho-kinase/ROKalpha/ROCKII, showed maximum inhibitory effect against ephrin-A5 (10 microg/ml)-induced growth cone collapse. Combined application of olomoucine and Y-27632 further suppressed the ephrin-A5-induced response. Ephrin-A5 evoked phosphorylation of Cdk5 at Tyr15 and tau, a substrate of Cdk5 in retinal growth cones. Recombinant herpes simplex virus expressing Cdk5 mutant (kinase-negative or Tyr15 to Ala) showed a dominant-negative effect on the ephrin-A5-induced growth cone collapse. These findings demonstrate that both Cdk5 and the Rho kinase pathway independently contribute to the downstream of ephrin-A-induced signaling in retinal ganglion cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Line
  • Cell Size / drug effects
  • Cell Size / physiology
  • Cells, Cultured
  • Chick Embryo
  • Cyclin-Dependent Kinase 5
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclin-Dependent Kinases / genetics
  • Cyclin-Dependent Kinases / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Ephrin-A5 / metabolism*
  • Ephrin-A5 / pharmacology
  • Growth Cones / drug effects
  • Growth Cones / metabolism*
  • Growth Cones / ultrastructure
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Mutation / genetics
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Phosphorylation / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism*
  • Receptor, EphA2 / drug effects
  • Receptor, EphA2 / metabolism
  • Retina / cytology
  • Retina / embryology
  • Retina / metabolism
  • Retinal Ganglion Cells / cytology
  • Retinal Ganglion Cells / drug effects
  • Retinal Ganglion Cells / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Superior Colliculi / cytology
  • Superior Colliculi / embryology
  • Superior Colliculi / metabolism
  • Visual Pathways / cytology
  • Visual Pathways / embryology
  • Visual Pathways / metabolism
  • rho-Associated Kinases

Substances

  • Enzyme Inhibitors
  • Ephrin-A5
  • Intracellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • neuronal Cdk5 activator (p25-p35)
  • Receptor, EphA2
  • Cyclin-Dependent Kinase 5
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases
  • CDK5 protein, human
  • Cyclin-Dependent Kinases